Coronavirus Update: Praised By Trump, Regeneron Files Antibody Cocktail For Emergency Use Authorization

Plus: India Blocks Russian Vaccine Trials

Regeneron
Regeneron believes it has enough data to support an EUA - but Trump's unfounded claims of a 'cure' muddy the water.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip